Search research articles
Contact Us
Filters
Showing results (141-150 of 302) with videos related to
Page
of 31
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
May 10, 2016
Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study
Shuji Otsuki, Salvatore Brugaletta, Manel Sabaté, et al.
JAMA Cardiology
|
March 25, 2026
Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial
Boris Schmidt, Stephan Windecker, David Thaler, et al.
The Canadian Journal of Cardiology
|
April 24, 2012
Long-term outcomes after percutaneous intervention of the internal thoracic artery anastomosis: the use of drug-eluting stents is associated with a higher need of repeat revascularization
Xavier Freixa, Mahendra Carpen, Mark A Kotowycz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 25, 2022
Usefulness of a novel sizing chart for left atrial appendage occlusion with the Amplatzer Amulet
Xavier Freixa, Pedro Cepas-Guillén, Kasper Korsholm, et al.
Journal of Thrombosis and Thrombolysis
|
July 29, 2025
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibition
Massimiliano Camilli, Giovanni Occhipinti, Nicola Potere, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
August 1, 2025
Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study
Atman P Shah, James V Freeman, Mohamad Alkhouli, et al.
Circulation. Cardiovascular Interventions
|
July 16, 2021
Ten-Year Outcomes Following Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Absolute or Relative Contraindications to Chronic Anticoagulation
Jules Mesnier, Ignacio Cruz-González, Vicente Peral, et al.
American Heart Journal
|
June 20, 2012
Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT)
Xavier Freixa, Vladimír Džavík, Sandra A Forman, et al.
Cardiology
|
July 10, 2024
The Association of Hematological Markers with Occurrence of Thrombotic and Bleeding Events following Left Atrial Appendage Occlusion
Errol Aarnink, Domenico Della Rocca, Pedro Cepas-Guillen, et al.
Journal of the American College of Cardiology
|
May 14, 2013
Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy
Marina Urena, Josep Rodés-Cabau, Xavier Freixa, et al.
Page
of 31
Search research articles
Search
Showing results (141-150 of 302) with videos related to
Sort By:
Page
of 31
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
May 10, 2016
Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study
Shuji Otsuki, Salvatore Brugaletta, Manel Sabaté, et al.
JAMA Cardiology
|
March 25, 2026
Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial
Boris Schmidt, Stephan Windecker, David Thaler, et al.
The Canadian Journal of Cardiology
|
April 24, 2012
Long-term outcomes after percutaneous intervention of the internal thoracic artery anastomosis: the use of drug-eluting stents is associated with a higher need of repeat revascularization
Xavier Freixa, Mahendra Carpen, Mark A Kotowycz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 25, 2022
Usefulness of a novel sizing chart for left atrial appendage occlusion with the Amplatzer Amulet
Xavier Freixa, Pedro Cepas-Guillén, Kasper Korsholm, et al.
Journal of Thrombosis and Thrombolysis
|
July 29, 2025
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibition
Massimiliano Camilli, Giovanni Occhipinti, Nicola Potere, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
August 1, 2025
Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study
Atman P Shah, James V Freeman, Mohamad Alkhouli, et al.
Circulation. Cardiovascular Interventions
|
July 16, 2021
Ten-Year Outcomes Following Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Absolute or Relative Contraindications to Chronic Anticoagulation
Jules Mesnier, Ignacio Cruz-González, Vicente Peral, et al.
American Heart Journal
|
June 20, 2012
Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT)
Xavier Freixa, Vladimír Džavík, Sandra A Forman, et al.
Cardiology
|
July 10, 2024
The Association of Hematological Markers with Occurrence of Thrombotic and Bleeding Events following Left Atrial Appendage Occlusion
Errol Aarnink, Domenico Della Rocca, Pedro Cepas-Guillen, et al.
Journal of the American College of Cardiology
|
May 14, 2013
Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy
Marina Urena, Josep Rodés-Cabau, Xavier Freixa, et al.
Page
of 31